Another new drug approved for registration under "1+" mechanism

A Government spokesman announced today (October 15) that one more new drug has been approved for registration under the "1+" drug approval mechanism, bringing the total number of new drugs approved for registration under this mechanism to 23. This new drug is used to treat patients with metastatic hormone-sensitive prostate cancer, bringing more treatment options for patients. The Government continues to accelerate the introduction of innovative drugs and medical devices so that patients can gain early access to advanced diagnoses and treatments, while developing Hong Kong into an international health and medical innovation hub. Another new drug approved ------------------------------- The "1+" mechanism has been implemented since November 1, 2023, to facilitate the registration of new drugs used for the treatment of serious or rare diseases in Hong Kong. With effect from November 1, 2024, the "1+" mechanism has been extended to all new drugs, including all new chemical or biological entities and new indications, and vaccines and advanced therapy products. New drugs that are supported by local clinical data and recognised by local experts can be applied for registration in Hong Kon

Résiliable à tout moment · 99 $ CA/mois